Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

The authors maintain there is a significant link between vitamin D deficiency and central centrifugal cicatricial alopecia in Black patients, and call for more research on the topic.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Accurate diagnosis is crucial for effective treatment of hair loss.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Hair shaft malformation contributes to Central Centrifugal Cicatricial Alopecia.

Fetal skin can heal without scars, offering insights for better wound treatments.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

CCCA can affect both genders and all ages, and it has a genetic component.

A woman's severe hair loss was caused by scalp psoriasis, not the initially thought condition, and treatment improved her psoriasis but couldn't restore her lost hair.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Enlarged sweat gland ducts may indicate scarring hair loss.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Low ferritin levels are linked to chronic hair loss in women.

Using dermoscopy improves diagnosis of scalp and hair disorders in children.

DNA analysis can help tailor alopecia treatment.

Trichoscopy helps diagnose scarring alopecia early and non-invasively.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.